Debashish Chatterjee, chief executive officer and managing director of LTIMindree talks about the growth drivers
CEO David Zaslav is evaluating various strategic paths, which may include asset sales or establishing a new entity for its Warner Bros movie studio and Max streaming service
The transition from blast furnace to EAF technology puts 2,800 jobs at risk and the Labour government has been engaging in discussions to try and save jobs, according to reports in the UK
Unilever recently told employees it will slash a third of office-based jobs in Europe by end of 2025
While founders have now become more prudent, there are firms that continue to burn cash to survive and may soon end up in the dead pool once their runway ends
QMS Medical Allied Services on Friday said it has acquired a 51 per cent stake in Saarathi Healthcare for Rs 450 crore. Mumbai-based QMS MAS is engaged in the marketing and distribution of a wide range of medical products. "The acquisition of Saarathi is the natural extension of our services and another step of our expansion plan. Where QMS MAS specializes in patient screening, Saarathi specializes in disease management leading to better disease outcomes essentially enabling us to provide a comprehensive portfolio to our clients," QMS Medical Allied Services CMD Mahesh Makhija said in a statement. This move will have a significant addition to company's revenues and profitability from the onset of the next fiscal year, he added. Saarathi Healthcare Founder & CEO Ranjeeta Vinil said the companies will forge ahead with collective strength in products and services.
The decommissioning of blast furnace number 5 was in sync with the timeline indicated by the company earlier
Restructuring of domestic operations over the next year, new launches, higher sales at subsidiary Jaguar Land Rover (JLR), and further deleveraging are key triggers for the stock
Pivot Robots, founded last year by two Carnegie Mellon University graduates Siddharth Girdhar and Vignesh Rajmohan, uses artificial intelligence to power automation in the manufacturing sector
A strong pipeline of large deals is expected to drive growth for the Bengaluru-based company
A South Korean business daily reported that the LG Group has approached foreign investment banks and local law firms to discuss the listing of LG Electronics in India's stock market
The Ministry of Corporate Affairs' investigation offers some relief to Byju's, as it temporarily halts any new scrutiny by Indian officials on already investigated issues
Decarbonisation at Ijmuiden plant will be in two phases, with one blast furnace to be replaced before 2030
The National Company Law Tribunal (NCLT) Bengaluru on June 12 told Byju's to maintain the status quo with regard to existing shareholders and their shareholding
PhonePe is in advanced talks with major smartphone manufacturers to include its homegrown Indus Appstore in their devices
Hindustan Zinc Ltd on Friday said it has partnered with US-based AEsir Technologies, Inc for development of next-generation zinc batteries. The company has signed a memorandum of understanding (MoU) with AEsir Technologies, Inc., a company that specialises in next-generation zinc battery technologies, to be the preferred supplier of zinc, a key raw material, Hindustan Zinc Ltd (HZL) said in a statement. The MoU is in line with the company's efforts towards exploring emerging applications of zinc in the clean energy transition, it said, adding that zinc batteries are revolutionising energy storage due to their corrosion resistance, cost-effectiveness, recyclability, stability and environmental friendliness. "This partnership with AEsir Technologies is yet another step in our ongoing developmental work in the emerging clean technology space. "By providing high-quality zinc for cutting-edge energy storage, we are opening sophisticated new avenues for environmentally friendly solutions
Sun Pharmaceutical Industries on Friday said it has inked a licensing pact with Takeda Pharmaceutical Company to commercialise a novel gastrointestinal drug in India. The company has entered into a non-exclusive patent licensing agreement with Takeda to commercialise Vonoprazan tablets in strengths of 10 and 20 mg in India, the Mumbai-based drug major said in a statement. Vonoprazan is a novel, orally active potassium competitive acid blocker (PCAB), used to treat reflux esophagitis and other acid peptic disorders. "Sun Pharma is a leader in gastroenterology and we are excited to introduce Vonoprazan in India under non-exclusive patent license from Takeda," Sun Pharma CEO - India Business Kirti Ganorkar said. The partnership demonstrates the company's commitment to gastrointestinal health by providing patients and healthcare practitioners with a novel treatment option to manage reflux esophagitis and other acid peptic disorders, he added. Gastroesophageal Reflux Disease (GERD) is
The company claimed that at Rs 2 crore, MISSO is priced around 66 per cent lower than the available robotic knee replacement systems in the Indian market
OrbitShift claims that it has reduced research and sales planning time by 40-50%